1,294
Participants
Start Date
October 31, 2005
Primary Completion Date
March 31, 2008
Study Completion Date
April 30, 2008
risedronate
tablet, 5 mg risedronate, once a day for 2 years
risedronate
oral, 150 mg risedronate, once a month for 2 years
Research Site, West Haverstraw
Research Site, Bethesda
Research Site, Gainesville
Research Site, Cincinnati
Research Site, Lakewood
Research Site, Portland
Research Site, Omaha
Research Site, Buenos Aires
Research Site, Capital Federal
Research Site, Geelong
Research Site, Heidelberg, Victoria
Research Site, Saint Leonards
Research Site, Brussels
Research Site, Ghent
Research Site, Leuven
Research Site, Liège
Research Site, Mont Godinne
Research Site, Rio de Janeiro
Research Site, São Paulo
Research Site, Calgary
Research Site, Montreal
Research Site, Sainte-Foy
Research Site, Saskatoon
Research Site, Pärnu
Research Site, Tartu
Research Site, Helsinki
Research Site, Kuopio
Research Site, Oulu
Research Site, Turku
Research Site, Amiens
Research Site, Lyon
Research Site, Orléans
Research Site, Paris
Research Site, Toulouse
Research Site, Vandœuvre-lès-Nancy
Research Site, Balatonfüred
Research Site, Budapest
Research Site, Győr
Research Site, Miskolc
Research Site, Nagykanizs
Research Site, Beirut
Research Site, Oslo
Research Site, Paradis
Research Site, Trondheim
Research Site, Bialystok
Research Site, Warsaw
Research Site, Barcelona
Research Site, Granada
Research Site, Madrid
Lead Sponsor
Collaborators (1)
Sanofi
INDUSTRY
Warner Chilcott
INDUSTRY